Caryn McDowell
Plus aucun poste en cours
Profil
Caryn G.
McDowell formerly worked at Affymax, Inc., as Executive Director-Corporate Law from 2012 to 2013, Onyx Pharmaceuticals, Inc., as Associate General Counsel & Head-US Healthcare Law in 2013, InterMune, Inc., as SVP, Deputy General Counsel & Assistant Secretary from 2014 to 2015, Cytokinetics, Inc., as Chief Compliance Officer & General Counsel from 2016 to 2018, Revance Therapeutics, Inc., as Secretary, Senior VP & General Counsel, State of Massachusetts, as Assistant Attorney General-Medicaid Fraud Control, US Department of Health & Human Services (DC), as Senior Counsel-Inspector General Office from 2001 to 2004, and Quince Therapeutics, Inc., as Secretary, Chief Administrative & Legal Officer from 2020 to 2022.
Ms. McDowell received her undergraduate degree from the University of Michigan and graduate degree from Boston University School of Law.
Anciens postes connus de Caryn McDowell
Sociétés | Poste | Fin |
---|---|---|
QUINCE THERAPEUTICS, INC. | Directeur Administratif | 08/07/2022 |
CYTOKINETICS, INCORPORATED | Compliance Officer | 01/05/2018 |
INTERMUNE INC | Corporate Officer/Principal | 01/02/2015 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Conseiller Juridique Général | 01/12/2013 |
AFFYMAX, INC. | Conseiller Juridique Général | 01/01/2013 |
Formation de Caryn McDowell
University of Michigan | Undergraduate Degree |
Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
AFFYMAX, INC. | Health Technology |
REVANCE THERAPEUTICS, INC. | Health Technology |
QUINCE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
US Department of Health & Human Services (DC) | Government |
State of Massachusetts | Government |